Arylazolyl(azinyl)thioacetanilides. Part 16: Structure-based bioisosterism design,synthesis and biological evaluation of novel pyrimidinylthioacetanilides as potent HIV-1 inhibitors |
| |
Institution: | 1. Bayer AG, Research and Development Pharmaceuticals, Wuppertal, Germany;2. CRS Clinical Research Services Wuppertal GmbH, Wuppertal, Germany |
| |
Abstract: | |
| |
Keywords: | HIV NNRTIs Pyrimidine Antiviral activity Drug design SAR SCR Molecular modeling |
本文献已被 ScienceDirect 等数据库收录! |
|